These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 20623259)

  • 1. Comparison of available treatments for tobacco addiction.
    Herman AI; Sofuoglu M
    Curr Psychiatry Rep; 2010 Oct; 12(5):433-40. PubMed ID: 20623259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current treatment options in smoking cessation.
    Crain D; Bhat A
    Hosp Pract (1995); 2010 Feb; 38(1):53-61. PubMed ID: 20469625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapy for smoking cessation: present and future.
    Aubin HJ; Karila L; Reynaud M
    Curr Pharm Des; 2011; 17(14):1343-50. PubMed ID: 21524268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tobacco smoking cessation management: integrating varenicline in current practice.
    Galanti LM
    Vasc Health Risk Manag; 2008; 4(4):837-45. PubMed ID: 19066000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of varenicline compared with bupropion, NRT, and nortriptyline for smoking cessation in the Netherlands.
    Hoogendoorn M; Welsing P; Rutten-van Mölken MP
    Curr Med Res Opin; 2008 Jan; 24(1):51-61. PubMed ID: 18021492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2012 Apr; (4):CD006103. PubMed ID: 22513936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.
    Athanasakis K; Igoumenidis M; Karampli E; Vitsou E; Sykara G; Kyriopoulos J
    Clin Ther; 2012 Aug; 34(8):1803-14. PubMed ID: 22818870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2011 Feb; (2):CD006103. PubMed ID: 21328282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2010 Dec; (12):CD006103. PubMed ID: 21154363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Varenicline: a pharmacoeconomic review of its use as an aid to smoking cessation.
    Keating GM; Lyseng-Williamson KA
    Pharmacoeconomics; 2010; 28(3):231-54. PubMed ID: 20108995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smoking cessation pharmacotherapy--nicotine and non-nicotine preparations.
    Frishman WH
    Prev Cardiol; 2007; 10(2 Suppl 1):10-22. PubMed ID: 17396063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current and future medical drugs for smoking cessation].
    Kusma B; Mache S; Deissenrieder F; Quarcoo D; Welte T; Groneberg D
    Laryngorhinootologie; 2009 Jun; 88(6):410-9; quiz 420-2. PubMed ID: 19504411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost effectiveness of varenicline in Belgium, compared with bupropion, nicotine replacement therapy, brief counselling and unaided smoking cessation: a BENESCO Markov cost-effectiveness analysis.
    Annemans L; Nackaerts K; Bartsch P; Prignot J; Marbaix S
    Clin Drug Investig; 2009; 29(10):655-65. PubMed ID: 19715382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Varenicline: a first-line treatment option for smoking cessation.
    Garrison GD; Dugan SE
    Clin Ther; 2009 Mar; 31(3):463-91. PubMed ID: 19393839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-nicotinic therapies for smoking cessation.
    Siu EC; Tyndale RF
    Annu Rev Pharmacol Toxicol; 2007; 47():541-64. PubMed ID: 17209799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maximizing smoking cessation in clinical practice: pharmacologic and behavioral interventions.
    Nides M; Leischow S; Sarna L; Evans SE
    Prev Cardiol; 2007; 10(2 Suppl 1):23-30. PubMed ID: 17396064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Which is the best primary medication for long-term smoking cessation--nicotine replacement therapy, bupropion or varenicline?
    Doggrell SA
    Expert Opin Pharmacother; 2007 Dec; 8(17):2903-15. PubMed ID: 18001252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2008 Jul; (3):CD006103. PubMed ID: 18646137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacotherapy for smoking cessation: pharmacological principles and clinical practice.
    Aubin HJ; Luquiens A; Berlin I
    Br J Clin Pharmacol; 2014 Feb; 77(2):324-36. PubMed ID: 23488726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse effects and tolerability of medications for the treatment of tobacco use and dependence.
    Hays JT; Ebbert JO
    Drugs; 2010 Dec; 70(18):2357-72. PubMed ID: 21142259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.